These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3158358)

  • 1. A stable isotope assay for phenprocoumon and its metabolites.
    Heimark LD; Trager WF
    Biomed Mass Spectrom; 1985 Feb; 12(2):67-71. PubMed ID: 3158358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biliary excretion of phenprocoumon and metabolites.
    de Vries JX; Raedsch R; Völker U; Walter-Sack I; Weber E
    Eur J Clin Pharmacol; 1988; 35(4):433-6. PubMed ID: 3197753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse phase high performance liquid chromatographic determination of phenprocoumon in tablets.
    Schmidt WF
    J Assoc Off Anal Chem; 1982 May; 65(3):753-5. PubMed ID: 7096256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sensitive and specific stable isotope assay for warfarin and its metabolites.
    Bush ED; Low LK; Trager WF
    Biomed Mass Spectrom; 1983 Jul; 10(7):395-8. PubMed ID: 6616017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gas chromatographic/mass spectrometric assay for catechol estrogens in microsomal incubations: comparison with a radiometric assay.
    Porubek DJ; Nelson SD
    Biomed Environ Mass Spectrom; 1988 Feb; 15(3):157-61. PubMed ID: 3284602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenprocoumon metabolites in human plasma; characterization by HPLC and GC-MS.
    de Vries JX; Zimmermann R; Harenberg J
    Eur J Clin Pharmacol; 1986; 29(5):591-4. PubMed ID: 3956564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic fate of phenprocoumon in humans.
    Toon S; Heimark LD; Trager WF; O'Reilly RA
    J Pharm Sci; 1985 Oct; 74(10):1037-40. PubMed ID: 4078699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereochemical aspects of the metabolism of phenprocoumon in rat liver microsomes.
    Wheeler C; Trager WF; Porter WR
    Biochem Pharmacol; 1981 Jul; 30(13):1785-90. PubMed ID: 7271865
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of the anticoagulant phenprocoumon in human plasma and urine by high-performance liquid chromatography.
    De Vries JX; Harenberg J; Walter E; Zimmermann R; Simon M
    J Chromatogr; 1982 Aug; 231(1):83-92. PubMed ID: 7119068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereospecific pharmacokinetic characterisation of phenprocoumon metabolites, and mass-spectrometric identification of two novel metabolites in human plasma and liver microsomes.
    Kammerer B; Kahlich R; Ufer M; Schenkel A; Laufer S; Gleiter CH
    Anal Bioanal Chem; 2005 Nov; 383(6):909-17. PubMed ID: 16237546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly sensitive and specific gas chromatographic-tandem mass spectrometric method for the determination of trace amounts of antipyrine metabolites in biological material.
    Engel G; Hofmann U; Eichelbaum M
    J Chromatogr B Biomed Appl; 1995 Apr; 666(1):111-6. PubMed ID: 7655608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans.
    Heimark LD; Toon S; Gibaldi M; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1987 Sep; 42(3):312-9. PubMed ID: 3621786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotransformation of phenprocoumon in the rat.
    Pohl LR; Haddock RE; Trager WF
    J Med Chem; 1975 May; 18(5):519-23. PubMed ID: 1151963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of phenprocoumon metabolites in human urine by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    De Vries JX; Simon M; Zimmermann R; Harenberg J
    J Chromatogr; 1985 Mar; 338(2):325-34. PubMed ID: 3998021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the metabolic profiles of R- and S-warfarin and R- and S-phenprocoumon as a probe to categorize the effect of inducing agents on microsomal hydroxylases.
    Porter WR; Wheeler C; Trager WF
    Biochem Pharmacol; 1981 Nov; 30(22):3099-104. PubMed ID: 7337727
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of dimethylbiguanide on phenprocoumon elimination and its mode of action. A drug interaction study.
    Ohnhaus EE; Berger W; Duckert F; Oesch F
    Klin Wochenschr; 1983 Sep; 61(17):851-8. PubMed ID: 6632727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial models of mammalian metabolism: production of novel alpha-diketone metabolites of warfarin and phenprocoumon using Aspergillus niger.
    Rizzo JD; Davis PJ
    Xenobiotica; 1988 Dec; 18(12):1425-37. PubMed ID: 3245234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation of the enantiomers of phenprocoumon and warfarin by high-performance liquid chromatography using a chiral stationary phase. Determination of the enantiomeric ratio of phenprocoumon in human plasma and urine.
    de Vries JX; Völker U
    J Chromatogr; 1989 Aug; 493(1):149-56. PubMed ID: 2778004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on metabolic pathways of cocaine and its metabolites using microsome preparations from rat organs.
    Toennes SW; Thiel M; Walther M; Kauert GF
    Chem Res Toxicol; 2003 Mar; 16(3):375-81. PubMed ID: 12641438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gas chromatographic-mass spectrometric analysis of alfentanil metabolites. Application to human liver microsomal alfentanil biotransformation.
    Labroo R; Kharasch ED
    J Chromatogr B Biomed Appl; 1994 Oct; 660(1):85-94. PubMed ID: 7858727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.